4.7 Article

Structural Analysis of Chemokine Receptor-Ligand Interactions

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 60, 期 12, 页码 4735-4779

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b01309

关键词

-

资金

  1. European Union [641833]
  2. Netherlands eScience Center (NLeSC)/NWO [027.014.201]
  3. NWO CW TOP-PUNT [718.014.002]
  4. 7 ways to 7TMR modulation (7-to-7)
  5. China Scholarship Council (CSC grant)

向作者/读者索取更多资源

This review focuses on the construction and application of structural chemokine receptor models for the elucidation of molecular determinants of chemokine receptor modulation and the structure-based discovery and design of chemokine receptor ligands. A comparative analysis of ligand binding pockets in chemokine receptors is presented, including a detailed description of the CXCR4, CCR2, CCRS, CCR9, and US28 X-ray structures, and their implication for modeling molecular interactions of chemokine receptors with small-molecule ligands, peptide ligands, and large antibodies and chemokines. These studies demonstrate how the integration of new structural, information on chemokine receptors with extensive structure-activity relationship and site-directed mutagenesis data facilitates the prediction of the structure, of chemokine receptor-ligand complexes that have not been crystallized. Finally, a review of structure-based ligand discovery and design studies based on chemokine receptor crystal structures and homology models illustrates the possibilities and challenges to find novel ligands for chemokine receptors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Engineering, Industrial

Absorbing knowledge from an emerging field: The role of interfacing by proponents in big pharma

Angelo K. S. Romasanta, Peter van der Sijde, Iwan J. P. de Esch

Summary: This study explores how researchers in big pharma firms engage with knowledge from an emerging field, and how they adapt their activities to overcome uncertainties. By focusing on internal and external activities, proponents of novel technologies bridge the developments in the field with the rest of the firm, leading to the adoption and development of the technology.

TECHNOVATION (2022)

Article Chemistry, Medicinal

Fragment-to-Lead Medicinal Chemistry Publications in 2020

Iwan J. P. de Esch, Daniel A. Erlanson, Wolfgang Jahnke, Christopher N. Johnson, Louise Walsh

Summary: The review summarizes successful fragment-to-lead studies published in 2020 and discusses trends and best practices in fragment libraries, target proteins, screening technologies, hit-optimization strategies, and properties of hit fragments and leads. Trends and innovations identified in the review promise to further increase the success of FBDD by developing novel screening fragments, improving screening technologies, using computer-aided design and virtual screening, and combining FBDD with other drug-discovery technologies.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Puckering the Planar Landscape of Fragments: Design and Synthesis of a 3D Cyclobutane Fragment Library

David J. Hamilton, Marieke Beemsterboer, Caroline M. Carter, Jasmina Elsayed, Rilana E. M. Huiberts, Hanna F. Klein, Peter O'Brien, Iwan J. P. de Esch, Maikel Wijtmans

Summary: Fragment-based drug discovery has a growing need for unique screening libraries. Cyclobutane moiety, identified as an attractive three-dimensional scaffold, was used to synthesize a library of novel 3D cyclobutane fragments. The library exhibited favorable shape and physicochemical properties compared to existing synthetic 3D fragment libraries.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

SAR exploration of the non-imidazole histamine H3 receptor ligand ZEL-H16 reveals potent inverse agonism

Gabor Wagner, Tamara A. M. Mocking, Xiaoyuan Ma, Inna Slynko, Daniel Da Costa Pereira, Robin Breeuwer, Niek J. N. Rood, Cas van der Horst, Henry F. Vischer, Chris de Graaf, Iwan J. P. de Esch, Maikel Wijtmans, Rob Leurs

Summary: In this study, the structure-activity relationship analysis of derivatives of ZEL-H16 revealed that both basic moieties and their distance from the central core are essential for H3R affinity. However, contrary to previous reports, ZEL-H16 and its derivatives were found to act as inverse agonists for G alpha(i) signaling in this study. Docking studies and molecular dynamics simulations identified ionic interactions/hydrogen bonds as crucial interaction points with H3R residues D114 and E206.

ARCHIV DER PHARMAZIE (2023)

Article Biochemistry & Molecular Biology

To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?

Yang Zheng, Susanne Schroeder, Georgi K. Kanev, Sanaa S. Botros, Samia William, Abdel-Nasser A. Sabra, Louis Maes, Guy Caljon, Carmen Gil, Ana Martinez, Irene G. Salado, Koen Augustyns, Ewald Edink, Maarten Sijm, Erik de Heuvel, Iwan J. P. de Esch, Tiffany van der Meer, Marco Siderius, Geert Jan Sterk, David Brown, Rob Leurs

Summary: This study investigated the potential of Schistosoma mansoni phosphodiesterase SmPDE4A as a new drug target for schistosomiasis. The researchers cloned, isolated, and characterized the full-length and catalytic domains of SmPDE4A. They found that SmPDE4A resembles human PDE4 more than parasite PDEs. Screening of PDE inhibitors identified tetrahydrophthalazinones and benzamides as potential hits, but further evaluation showed that the inhibitors were not effective against S. mansoni, suggesting that SmPDE4A is not a suitable target for anti-schistosomiasis therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Green Drug Discovery: Novel Fragment Space from the Biomass-Derived Molecule Dihydrolevoglucosenone (Cyrene™)

Tom Dekker, Jaap W. W. Harteveld, Gabor Wagner, Max C. M. de Vries, Hans Custers, Andrea C. van de Stolpe, Iwan J. P. de Esch, Maikel Wijtmans

Summary: Biomass-derived molecules have the potential for sustainable drug discovery, but their exploration is hindered by the dominance of old-fashioned screening compounds in classical high-throughput screening libraries. We propose a fragment-based drug discovery approach as an efficient method to navigate biomass-derived drug space. In a proof-of-concept study using dihydrolevoglucosenone (Cyrene TM), we generated a diverse fragment library with good physicochemical properties and potential for novel drug candidates based on renewable resources.

MOLECULES (2023)

Article Multidisciplinary Sciences

Micro-foundations of dynamic capabilities to facilitate university technology transfer

Zhongxuan Ma, K. D. Augustijn, I. J. P. De Esch, B. A. G. Bossink

Summary: This study investigates the micro-foundations of dynamic capabilities in university technology transfer through qualitative case studies at two organizations. The micro-foundations of sensing include selecting internal competency and sensing external partners, while seizing involves resource co-allocation and collaborative business model. The micro-foundations of reconfiguring include strategic renewal, establishing a university technology transfer-friendly environment, and asset orchestration. This study provides better understanding of how dynamic capabilities facilitate university technology transfer, and offers suggestions for industrial practitioners and policymakers.

PLOS ONE (2023)

Article Chemistry, Medicinal

An Automated, Open-Source Workflow for the Generation of (3D) Fragment Libraries

Tom Dekker, Mathilde A. C. H. Janssen, Christina Sutherland, Rene W. M. Aben, Hans W. Scheeren, Daniel Blanco-Ania, Floris P. J. T. Rutjes, Maikel Wijtmans, Iwan J. P. de Esch

Summary: The success of fragment-based drug discovery (FBDD) is closely related to library design. A workflow in KNIME software has been created to guide the design of fragment libraries, considering chemical diversity and novelty of the fragments, as well as their three-dimensional (3D) character. This design tool can create large and diverse libraries or select representative compounds to enrich existing libraries.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Article Biology

Monitoring Snake Venom-Induced Extracellular Matrix Degradation and Identifying Proteolytically Active Venom Toxins Using Fluorescently Labeled Substrates

Matyas A. Bittenbinder, Nick D. Bergkamp, Julien Slagboom, Jan Paul M. Bebelman, Nicholas R. Casewell, Marco H. Siderius, Martine J. Smit, Jeroen Kool, Freek J. Vonk

Summary: Snakebite envenoming is a significant public health concern with high mortality rates. Snake venoms can have various harmful effects on the body, including tissue damage. This study presents a workflow using fluorescently labeled ECM components to investigate the degradation of ECM caused by snake venom. This approach provides valuable insights into the mechanisms of proteolytic venom components and could aid in the development of effective snakebite treatments.

BIOLOGY-BASEL (2023)

Article Chemistry, Medicinal

PSW-Designer: An Open-Source Computational Platform for the Design and Virtual Screening of Photopharmacological Ligands

Icaro A. Simon, Evert J. Homan, Maikel Wijtmans, Michael Sundstrom, Rob Leurs, Iwan J. P. De Esch, Barbara A. Zarzycka

Summary: The researchers have developed an open-source computational platform, called PSW-Designer, for the design and screening of new photoswitchable ligands, especially for GPCRs. Through two case studies, they validate the predictive capabilities of the platform and anticipate that it will facilitate the design of improved photoswitchable molecules.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Review Chemistry, Physical

Alchemical Free Energy Calculations on Membrane-Associated Proteins

Michail Papadourakis, Hryhory Sinenka, Pierre Matricon, Jerome Henin, Grace Brannigan, Laura Perez-Benito, Vineet Pande, Herman van Vlijmen, Chris de Graaf, Francesca Deflorian, Gary Tresadern, Marco Cecchini, Zoe Cournia

Summary: This article reviews the progress in alchemical free energy calculations of membrane proteins, focusing on best practices and critical aspects of simulations on G-protein-coupled receptors, ion channels, transporters, and protein-lipid interactions. The study reveals the valuable application of alchemical free energy calculations in drug discovery for membrane-associated proteins.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2023)

Article Biochemistry & Molecular Biology

A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P(1) signaling axis

Nick D. Bergkamp, Jeffrey R. van Senten, Hendrik J. Brink, Maarten P. Bebelman, Jelle van den Bor, Tugce S. Cobanoglu, Kasper Dinkla, Johannes Koester, Gunnar Klau, Marco Siderius, Martine J. Smit

Summary: The G-protein coupled receptor US28 encoded by human cytomegalovirus (HCMV) is associated with accelerated progression of glioblastomas. In this study, it was found that US28 enhances signaling mediated by sphingosine-1-phosphate (S1P), promoting glioblastoma cell proliferation and survival. The study also uncovers the roles of S1P and CIP2A in US28-mediated exacerbation of glioblastoma.

SCIENCE SIGNALING (2023)

Article Multidisciplinary Sciences

Exosomal release of the virus-encoded chemokine receptor US28 contributes to chemokine scavenging

Maarten P. Bebelman, Irfan M. Setiawan, Nick D. Bergkamp, Jeffrey R. van Senten, Caitrin Crudden, Jan Paul M. Bebelman, Frederik J. Verweij, Guillaume van Niel, Marco Siderius, D. Michiel Pegtel, Martine J. Smit

Summary: The HCMV-encoded chemokine receptor US28 plays a role in various aspects of the viral life cycle and immune evasion by scavenging chemokines from HCMV-infected cells. It localizes to late endosomal compartments called multivesicular bodies (MVBs) and can be secreted on exosomes through fusion with the plasma membrane. The exosomal release of US28 contributes to chemokine scavenging and immune evasion by HCMV.

ISCIENCE (2023)

Article Biochemical Research Methods

NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET

Jelle van den Bor, Nick D. Bergkamp, Stephanie M. Anbuhl, Francoise Dekker, Dehan Comez, Claudia V. Perez Almeria, Reggie Bosma, Carl W. White, Laura E. Kilpatrick, Stephen J. Hill, Marco Siderius, Martine J. Smit, Raimond Heukers

Summary: The use of nanobodies and NanoBRET methods allows for real-time monitoring of nanobody-receptor binding, predicting the therapeutic potential of ligands targeting disease-associated membrane proteins, which is significant for drug research.

CELL REPORTS METHODS (2023)

Letter Oncology

Molecular characterization of the CXCR4 / CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugates

Gamal A. Wakileh, Philipp Bierholz, Mara Kotthoff, Margaretha A. Skowron, Felix Bremmer, Alexa Stephan, Stephanie M. Anbuhl, Raimond Heukers, Martine J. Smit, Philipp Stroebel, Daniel Nettersheim

Summary: This study identified a nanobody-drug-conjugate targeting CXCR4 as a potential therapeutic option for GCT. Furthermore, this study shed light on the functional role of the CXCR4 / CXCR7 / CXCL12-signaling cascade in GCT, demonstrating an important influence on proliferation and migration.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2023)

暂无数据